N¹-(4-methoxybenzyl)propane-1,3-diamine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N¹-(4-methoxybenzyl)propane-1,3-diamine
• 英文别名: N-(4-methoxybenzyl)propane-1,3-diamine；N'-[(4-methoxyphenyl)methyl]propane-1,3-diamine
• 化学式: C₁₁H₁₈N₂O
• mdl: MFCD06661417
• 分子量: 194.277
• InChiKey: GOPCLQUKFLLWCG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  47.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl [4-(chloroacetyl)-1-(2-chlorophenyl)-5-hydroxy-1H-pyrazol-3-yl]acetate 、 N¹-(4-methoxybenzyl)propane-1,3-diamine 在 N,N-二异丙基乙胺 作用下， 以 乙腈 为溶剂， 反应 4.0h， 生成
  参考文献：
  名称：

  Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors

  摘要：

  Pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives are new chemical entities with good and attractive druglikeness properties. A series of pyrazolo-pyrido-diazepine dione analogs demonstrated to be particularly amenable to lead optimization through a couple of cycles in order to improve specificity for isoforms Nox4 and Nox1 and had excellent pharmacokinetic parameters by oral route. Several molecules such as compound 7c proved to be highly potent in in vitro assays on human lung fibroblasts differentiation as well as in curative murine models of bleomycin-induced pulmonary fibrosis with superior efficiency over Pirfenidone. Pyrazolo-pyrido-diazepine dione derivatives targeting Nox4 and Nox1 isoforms appear highly promising therapeutics for the treatment of idiopathic pulmonary fibrosis. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.10.016
• 作为产物：
  描述：

  4-甲氧基苯甲醛 、 1,3-丙二胺 在 sodium tetrahydroborate 作用下， 以 甲苯 、 乙醇 为溶剂， 反应 9.0h， 以51%的产率得到N¹-(4-methoxybenzyl)propane-1,3-diamine
  参考文献：
  名称：

  新型取代萘二酰亚胺作为抗癌剂的构效关系

  摘要：

  合成了新型的1,4,5,8-萘四甲酸二酰亚胺（NDI）衍生物，并评估了它们在多种不同肿瘤细胞系中的抗增殖活性。本系列的原型是衍生物1和2，其特征在于有趣的生物学特性作为抗癌剂。本研究扩展了原型1和原型2的结构与活性关系的研究，即苯环的不同取代基对生物活性的影响。衍生工具3 – 22以芳香环上不同的取代基和/或从两个碳原子单元到三个碳原子单元的不同链长为特征的α，β-环糊精被合成，并对其细胞抑制活性和细胞毒性活性进行了评估。最有趣的化合物是20，其特征在于三个亚甲基单元和两个芳环上的2,3,4-三甲氧基取代基的连接基。它显示出在亚微摩尔范围内的抗增殖活性，尤其是针对某些不同的细胞系，具有抑制Taq聚合酶和端粒酶，通过可能的氧化机制触发caspase活化，下调ERK 2蛋白和抑制ERKs磷酸化的能力，而没有直接作用于微管和微管。它对双链和四链DNA结构的理论认识已与实验热力学测量结果进行了比较

  DOI：

  10.1016/j.ejmech.2012.06.045

文献信息

• Synthesis of Platinum Complexes from N-Benzyl-1,3-Propanediamine Derivatives, Potential Antineoplastic Agents
  作者：Mauro De Almeida、Ana Fontes、Richard Berg、Eloi César、Emanoel De Castro Antunes Felício、José De Souza Filho

  DOI：10.3390/70400405

  日期：——

  This work describes the synthesis of seven new platinum complexes having N-benzyl 1,3-propanediamine derivatives as ligands. They were prepared by the reaction of K2[PtCl4] with the appropriate ligand in water. These complexes are analogs of cisplatin, and are potential antineoplastic agents.

  这项工作描述了以 N-苄基 1,3-丙二胺衍生物作为配体的七种新铂配合物的合成。它们是通过 K2[PtCl4] 与适当的配体在水中反应制备的。这些复合物是顺铂的类似物，是潜在的抗肿瘤剂。
• AMINOALCOHOL LIPIDOIDS AND USES THEREOF
  申请人：Mahon Kerry Peter

  公开号：US20110293703A1

  公开（公告）日：2011-12-01

  Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.

  本文描述了通过将胺与环氧末端化合物反应制备氨基醇脂质体的方法。还提供了从商业起始材料制备氨基醇脂质体的方法。氨基醇脂质体可以从外消旋或立体化学纯的环氧化合物制备。氨基醇脂质体或其盐形式最好是可生物降解和生物相容的，并可用于各种药物输送系统。鉴于这些氨基醇脂质体化合物的氨基基团，它们特别适用于多核苷酸的输送。已经制备了包含创新脂质体和多核苷酸的复合物、胶束、脂质体或粒子。创新脂质体也可以用于制备药物输送的微粒。鉴于它们能够缓冲其周围环境的pH值，它们在输送不稳定剂方面特别有用。
• Nitromethylen-tetrahydropyrimidine
  申请人：NIHON TOKUSHU NOYAKU SEIZO K.K.

  公开号：EP0199974A2

  公开（公告）日：1986-12-10

  Die vorliegende Erfindung betrifft neue Nitromethylen-tetrahydropyrimidin-Derivate der Formel (I) in der R eine Alkyl-Gruppe, eine Alkoxy-Gruppe, eine Alkylthio-Gruppe, eine Nitro-Gruppe, eine Cyano-Gruppe, eine halogen-substituierte Alkyl-Gruppe, eine halogen-substituierte Alkoxy-Gruppe, eine halogen-substituierte Alkylthio-Gruppe, eine Amino-Gruppe, eine Dialkylamino-Gruppe, eine Acylamino-Gruppe, eine Carboxyl-Gruppe, eine Alkoxycarbonyl-Gruppe, eine Alkylsulfinyl-Gruppe, eine Alkylsulfonyl-Gruppe oder ein Halogen-Atom bezeichnet und n 1, 2 oder 3 bezeichnet, jedoch mit der Maßgabe, daß, wenn n für 1 steht, R nicht ein Halogen-Atom bezeichnen darf, Verfahren zur Herstellung der Verbindungen (I) sowie die Verwendung der neuen Verbindungen als Pestizide, insbesondere als Insektizide.

  本发明涉及式 (I) 的新型硝基亚甲基四氢嘧啶衍生物 其中 R 表示烷基、烷氧基、烷硫基、硝基、氰基、卤素取代的烷基、卤素取代的烷氧基、卤素取代的烷硫基、氨基、二烷基氨基、酰氨基、羧基、烷氧羰基、烷基亚磺酰基、烷基磺酰基或卤素原子，以及 n 表示 1、2 或 3，但当 n 为 1 时，R 不得表示卤素原子、 化合物(I)的制备工艺以及新化合物作为杀虫剂，特别是杀虫剂的用途。
• POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF
  申请人：Ma Minglin

  公开号：US20130302401A1

  公开（公告）日：2013-11-14

  A new class of poly(beta-amino alcohols) (PBAAs) has been prepared using combinatorial polymerization. The inventive PBAAs may be used in biotechnology and biomedical applications as coatings (such as coatings of films or multilayer films for medical devices or implants), additives, materials, excipients, non-biofouling agents, micropatterning agents, and cellular encapsulation agents. When used as surface coatings, these PBAAs elicited different levels of inflammation, both in vitro and in vivo, depending on their chemical structures. The large chemical diversity of this class of materials allowed us to identify polymer coatings that inhibit macrophage activation in vitro. Furthermore, these coatings reduce the recruitment of inflammatory cells, and reduce fibrosis, following the subcutaneous implantation of carboxylated polystyrene microparticles. These polymers may be used to form polyelectrolyte complex capsules for cell encapsulation. The invention may also have many other biological applications such as antimicrobial coatings, DNA or siRNA delivery, and stem cell tissue engineering.
• ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF
  申请人：Massachusetts Institute of Technology

  公开号：US20140322309A1

  公开（公告）日：2014-10-30

  α-Aminoamidine polymers and methods of preparing a-aminoamidine polymers by reacting by reacting one or more amines with one or more isocyanides and one or more aldehydes are described. Methods of preparing a-aminoamidine polymers from commercially available starting materials are also provided, wherein the starting materials are racemic or stereochemically pure. a-Aminoamidine polymers or salt forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems and for other purposes as well such as, for example, coatings, additives, excipients, plastics, and materials, etc. Given the amino moiety of these α-aminoamidine polymers, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive α-aminoamidine polymers and polynucleotides can be prepared. The inventive α-aminoamidine polymers may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.